Digestive System Helicobacter pylori
Conditions
Interventions
Cla group
Sponsors
Galpharma
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Age 18 to 60 years. Patients with H. pylori infection documented by pathological evidence (gastric biopsy), by breath test or by H. pylori Antigen in stool and who have never received H. pylori eradication treatment. Patients who gave informed consent for participation in our research.
Exclusion criteria
Exclusion criteria: Patient has serious underlying diseases such as hepatic failure, renal failure , immunosuppression, malignancies, coronary artery disease, or severe psychiatric or neurological disorders. The patient is a pregnant or lactating woman. Patient has active gastrointestinal bleeding or a history of upper gastrointestinal surgery. The patient is allergic to the drugs in the treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Compare the Helicobacter pylori eradication rate of the two tested regimens | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse event rates ;Patient compliance: Good compliance is defined as the actual dose being within 80-100% of the dose that should be taken. ;Cost-effectiveness index: Ratio of cost to effectiveness | — |
Countries
Tunisia
Contacts
Public ContactSonia Bostani
resident
Outcome results
None listed